José Ricardo J, Williams Andrew E, Mercer Paul F, Sulikowski Michal G, Brown Jeremy S, Chambers Rachel C
Centre for Inflammation and Tissue Repair, University College London, London WC1E 6JF, United Kingdom.
Centre for Inflammation and Tissue Repair, University College London, London WC1E 6JF, United Kingdom
J Immunol. 2015 Jun 15;194(12):6024-34. doi: 10.4049/jimmunol.1500124. Epub 2015 May 6.
Neutrophils are key effector cells of the innate immune response to pathogenic bacteria, but excessive neutrophilic inflammation can be associated with bystander tissue damage. The mechanisms responsible for neutrophil recruitment to the lungs during bacterial pneumonia are poorly defined. In this study, we focus on the potential role of the major high-affinity thrombin receptor, proteinase-activated receptor 1 (PAR-1), during the development of pneumonia to the common lung pathogen Streptococcus pneumoniae. Our studies demonstrate that neutrophils were indispensable for controlling S. pneumoniae outgrowth but contributed to alveolar barrier disruption. We further report that intra-alveolar coagulation (bronchoalveolar lavage fluid thrombin-antithrombin complex levels) and PAR-1 immunostaining were increased in this model of bacterial lung infection. Functional studies using the most clinically advanced PAR-1 antagonist, SCH530348, revealed a key contribution for PAR-1 signaling in influencing neutrophil recruitment to lung airspaces in response to both an invasive and noninvasive strain of S. pneumoniae (D39 and EF3030) but that PAR-1 antagonism did not impair the ability of the host to control bacterial outgrowth. PAR-1 antagonist treatment significantly decreased pulmonary levels of IL-1β, CXCL1, CCL2, and CCL7 and attenuated alveolar leak. Ab neutralization studies further demonstrated a nonredundant role for IL-1β, CXCL1, and CCL7 in mediating neutrophil recruitment in response to S. pneumoniae infection. Taken together, these data demonstrate a key role for PAR-1 during S. pneumoniae lung infection that is mediated, at least in part, by influencing multiple downstream inflammatory mediators.
中性粒细胞是对病原菌先天性免疫反应的关键效应细胞,但过度的嗜中性粒细胞炎症可能与旁观者组织损伤有关。细菌性肺炎期间中性粒细胞募集到肺部的机制尚不清楚。在本研究中,我们聚焦于主要的高亲和力凝血酶受体——蛋白酶激活受体1(PAR-1)在肺炎发展过程中对常见肺部病原体肺炎链球菌的潜在作用。我们的研究表明,中性粒细胞对于控制肺炎链球菌的生长不可或缺,但会导致肺泡屏障破坏。我们进一步报道,在这种细菌性肺部感染模型中,肺泡内凝血(支气管肺泡灌洗 fluid 凝血酶-抗凝血酶复合物水平)和PAR-1免疫染色增加。使用临床上最先进的PAR-1拮抗剂SCH530348进行的功能研究表明,PAR-1信号传导在影响中性粒细胞募集到肺空域以应对肺炎链球菌的侵袭性和非侵袭性菌株(D39和EF3030)方面起关键作用,但PAR-1拮抗作用并不损害宿主控制细菌生长的能力。PAR-1拮抗剂治疗显著降低了肺部IL-1β、CXCL1、CCL2和CCL7的水平,并减轻了肺泡渗漏。抗体中和研究进一步证明了IL-1β、CXCL1和CCL7在介导对肺炎链球菌感染的中性粒细胞募集中的非冗余作用。综上所述,这些数据表明PAR-1在肺炎链球菌肺部感染中起关键作用,这至少部分是通过影响多种下游炎症介质介导的。